Journal of Medical Economics, Volume 18, Issue 5 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 18, Issue 5 (2015)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Volume 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Original article

Article
The economic implications of switching to rivaroxaban from enoxaparin plus vitamin K antagonist in the treatment of venous thromboembolism
Aarti A. Patel, Kristine Ogden, Samir H. Mody & Brahim Bookhart
Pages: 323-332
Published online: 05 Jan 2015
AbstractforThe economic implications of switching to rivaroxaban from enoxaparin plus vitamin K antagonist in the treatment of venous thromboembolism | Full Text | References | PDF (303.4 KB)
  • 560 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation
Winnie W. Nelson, Li Wang, Onur Baser, C. V. Damaraju & Jeffrey R. Schein
Pages: 333-340
Published online: 06 Feb 2015
AbstractforOut-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation | Full Text | References | PDF (205.6 KB)
  • 465 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Infectious Disease: Brief report

An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States
Anita H. Sung, Stephen W. Marcella & Yang Xie
Pages: 341-348
Published online: 02 Mar 2015
AbstractforAn update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States | Full Text | References | PDF (154.1 KB)
  • 970 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access

Original article

Article
Direct medical costs for patients with tuberous sclerosis complex and surgical resection of subependymal giant cell astrocytoma: a US national cohort study
Peter Sun, Zhimei Liu, Darcy Krueger & Michael Kohrman
Pages: 349-356
Published online: 03 Feb 2015
AbstractforDirect medical costs for patients with tuberous sclerosis complex and surgical resection of subependymal giant cell astrocytoma: a US national cohort study | Full Text | References | PDF (261.2 KB)
  • 536 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Healthcare utilization and costs of veterans health administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics
Onur Baser, Lin Xie, Jacqueline Pesa & Mike Durkin
Pages: 357-365
Published online: 19 Jan 2015
AbstractforHealthcare utilization and costs of veterans health administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics | Full Text | References | PDF (297.4 KB)
  • 1532 Views
  • 51 CrossRef citations
  • 0Altmetric
Free Access
Article
Key data elements for use in cost-utility modeling of biological treatments for rheumatoid arthritis
Michael L. Ganz, Brian Bekker Hansen, Xavier Valencia & Martin Strandberg-Larsen
Pages: 366-375
Published online: 19 Jan 2015
AbstractforKey data elements for use in cost-utility modeling of biological treatments for rheumatoid arthritis | Full Text | References | PDF (165.2 KB)
  • 469 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis
Machaon Bonafede, Barbara H. Johnson, Nicole Princic, Neel Shah & David J. Harrison
Pages: 376-389
Published online: 28 Jan 2015
AbstractforCost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis | Full Text | References | PDF (241.3 KB)
  • 1062 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic evaluation of pharmacological treatments for overactive bladder from the perspective of the UK National Health Service
Jameel Nazir, John Posnett, Anna Walker, Isaac A. Odeyemi, Zalmai Hakimi & Andrew Garnham
Pages: 390-397
Published online: 19 Dec 2014
AbstractforEconomic evaluation of pharmacological treatments for overactive bladder from the perspective of the UK National Health Service | Full Text | References | PDF (228.5 KB)
  • 1853 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Explore articles